Re: Illicit Opioid Use and its Key Characteristics: A Select Overview and Evidence from a Canadian Multisite Cohort of Illicit Opioid Users

Fischer B Cruz M Firestone Rehm J. Illicit opiod use and its key characteristics: A select overview and evidence from a Canadian multisite cohort of illicit opiod users (OPICAN). Can J Psychiatry. 2006;51(10):624–634.

van den Brink W Haasen C. Evidence-based treatment of opioid-dependent patients. Can J Psychiatry. 2006;51(10):635–646.

Montoya ID Gorelick DA Preston KL Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence. Clin Pharmacol Ther. 2004;75(1):34–48.

Sigmon SC Moody DE Nuwayser ES An injection depot formulation of buprenorphine: Extended bio-delivery and effects. Addiction. 2006;101(3):420–432.

Sobel BF Sigmon SC Walsh SL Open-label trial of an injection depot formulation of buprenorphine in opioid detoxification. Drug Alcohol Depend. 2004;73(1):11–22.